Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.
The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option.
America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention.
RAP Protein Gummies brought a protein gummy product to market Wednesday.
AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.
Merck on Thursday announced that the Food and Drug Administration granted accelerated approval to Keytruda (pembrolizumab) for the treatment of patients with advanced melanoma.
Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.
Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.
Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug.
Procter & Gamble on Wednesday announced the introduction of Vicks QlearQuil, a family of over-the-counter medications for the occasional allergy sufferer.